| Serial Number | 90420110 |
| Word Mark | SANGAMO THERAPEUTICS |
| Filing Date | Monday, December 28, 2020 |
| Status | 734 - FIFTH EXTENSION - GRANTED |
| Status Date | Friday, August 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 28, 2021 |
| Description of Mark | The mark consists of the wording "SANGAMO" in a stylized font with the letter "O" in "SANGAMO" comprised of two concentric circles with the outer circle being broken by two diagonal lines and the word "THERAPEUTICS" in a stylized font is centered below the letters "AMO" in the wording "SANGAMO". |
| Goods and Services | Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use |
| Goods and Services | Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use |
| Goods and Services | Licensing of intellectual property rights |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 17, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 17, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 17, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 17, 2021 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sangamo Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Richmond, CA 94804 |
| Party Name | Sangamo Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Atlanta, GA 30309 |
| Event Date | Event Description |
| Thursday, December 31, 2020 | NEW APPLICATION ENTERED |
| Thursday, June 24, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, June 30, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 17, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 18, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, June 30, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 30, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, November 15, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 15, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 15, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 23, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 8, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 28, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 28, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 22, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, August 22, 2022 | SOU EXTENSION 1 FILED |
| Monday, August 22, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 22, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, August 22, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 22, 2022 | FAX RECEIVED |
| Thursday, September 15, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 15, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, September 15, 2022 | ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST |
| Monday, September 19, 2022 | RESPONSE TO ITU OFFICE ACTION ENTERED |
| Monday, September 19, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 21, 2022 | SOU EXTENSION 1 GRANTED |
| Thursday, September 22, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 15, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 15, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 20, 2023 | SOU EXTENSION 2 FILED |
| Monday, February 20, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 20, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, February 22, 2024 | SOU EXTENSION 4 GRANTED |
| Wednesday, February 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 18, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 18, 2023 | SOU EXTENSION 3 FILED |
| Friday, August 18, 2023 | SOU EXTENSION 3 GRANTED |
| Tuesday, August 22, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 22, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 22, 2024 | SOU EXTENSION 4 FILED |
| Friday, February 23, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 9, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 9, 2024 | SOU EXTENSION 5 FILED |
| Friday, August 9, 2024 | SOU EXTENSION 5 GRANTED |